TABLE 3.
Clinical feature | Group | n | Mean | SD | t | P value | Adjusted P value |
Age | ≥60 | 54 | 1.489 | 1.152 | 2.054 | 0.043* | 0.258 |
<60 | 73 | 1.113 | 0.809 | ||||
Gender | Female | 57 | 1.25 | 1.05 | –0.226 | 0.821 | 1.000 |
Male | 70 | 1.291 | 0.933 | ||||
Blast cell | High | 65 | 1.312 | 0.902 | 0.453 | 0.652 | 1.000 |
Low | 62 | 1.232 | 1.068 | ||||
Bone marrow blast cell | High | 64 | 1.351 | 1.094 | 0.907 | 0.366 | 1.000 |
Low | 63 | 1.193 | 0.858 | ||||
Hemoglobin | High | 102 | 1.229 | 0.882 | –0.794 | 0.434 | 1.000 |
Low | 25 | 1.451 | 1.326 | ||||
Leukocyte | High | 64 | 1.47 | 1.16 | 2.326 | 0.022* | 0.154 |
Low | 63 | 1.072 | 0.718 | ||||
FAB | M3 | 13 | 0.457 | 0.341 | –6.863 | 0.000*** | 0.000 |
non-M3 | 114 | 1.366 | 0.99 | ||||
Cytogenetics risk | Favorable + Normal | 100 | 1.266 | 1.015 | –0.164 | 0.870 | 1.000 |
Poor | 27 | 1.298 | 0.874 |
*p < 0.05, ***p < 0.001.